Request Legal Help Now - Free


Pradaxa Bleeding Side Effects Lawsuit

Read our Pradaxa FAQ
Were you looking for Anti-Coagulation Medication lawsuits?

Pradaxa side effects reportedly include a risk of Pradaxa bleeding, according to reports from the European Medicines Agency. Pradaxa, known generically as dabigatran, has been linked to between 50 and 256 deaths that reportedly involved Pradaxa side effects. Some victims have filed a Pradaxa lawsuit alleging excessive bleeding.


Send your Pradaxa claim to a lawyer who will review your claim at NO COST or obligation.

Pradaxa Side Effects

Pradaxa is an anticoagulant (used to prevent blood clots) medication designed to replace warfarin. It is used to prevent strokes in patients who suffer from atrial fibrillation. Patients with atrial fibrillation may be at a higher risk of blood clots, which can cause a stroke if they travel to the brain. In some countries, Pradaxa is approved to prevent venous thromboembolism, although it is not approved in the US for this use.

Pradaxa has been linked to an increased risk of bleeding, a common side effect in anti-blood clotting medications.

Pradaxa Deaths

In December 2011, the US Food and Drug Administration (FDA) announced it was conducting a safety review of Pradaxa. The announcement was made after FDA received postmarketing reports linking the use of Pradaxa to serious bleeding events. When the FDA made its announcement, it said that it currently believes the medication provides an important health benefit and patients should not discontinue medication without speaking to their healthcare provider.

Although the Pradaxa warning label contains information about the risk of bleeding, the FDA is working to determine whether bleeding events are occurring with Pradaxa patients more frequently than expected. According to Pradaxa's maker, there were reportedly 260 reports of fatal bleeding incidents worldwide associated with Pradaxa use.

Pradaxa Heart Attack

A study published in January 2012 in the Archives of Internal Medicine suggested a link between the use of Pradaxa and a slightly higher risk of heart attack or acute coronary syndrome when compared with similar medicines. Researchers compared the use of Pradaxa to warfarin, enoxaparin or a placebo and found that the relative increase in risk ranged from 27 to 33 percent in patients who used Pradaxa.

Researchers recommended that further study be done on the increased risk of heart attacks in patients who take Pradaxa and that clinicians weigh the risks of Pradaxa along with the benefits.

Pradaxa Dabigatran

Pradaxa is made by Boehringer Ingelheim. It was approved for use in October 2010 and is known as a direct thrombin inhibitor. Pradaxa is available in 75 mg and 150 mg capsules.

Pradaxa Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a Pradaxa lawyer who may evaluate your claim at no cost or obligation.
Last updated on


$28M Xarelto Verdict Against J&J and Bayer
$28M Xarelto Verdict Against J&J and Bayer
December 5, 2017
Philadelphia, PA: A jury has found against units of Johnson & Johnson (J&J) and Bayer AG in the fourth bellwether Xarelto (Rivaroxaban) case being heard as part of a Xarelto mass tort. The award, nearly $28 million, is the first favoring a plaintiff, in this case Lynn Hartman, who alleged she suffered a serious gastrointestinal bleed while using the blood thinning medication. The jury found that the pharmaceutical companies failed to provide adequate warnings regarding the risks for bleeding associated with Xarelto. READ MORE

Pradaxa Lawsuits Allege Pradaxa Bleeding Risk, Insufficient Warnings
Pradaxa Lawsuits Allege Pradaxa Bleeding Risk, Insufficient Warnings
January 4, 2017
Hartford, CT: Even though Pradaxa and a competitor were brought to market as an easier-to-manage alternative to warfarin, previously the gold standard for blood thinning, no one disputes the fact that all anti-coagulants carry a risk for bleeding events. However, it is alleged in Pradaxa lawsuits that some blood thinners carry a greater risk for bleeding events than others. READ MORE

Pradaxa Bleeding Risk Increased With Certain Statins: Study
Pradaxa Bleeding Risk Increased With Certain Statins: Study
December 4, 2016
Toronto, ON: In tandem with oft-cited Pradaxa bleeding associated with the frequently-prescribed blood thinner, a new concern has emerged from a Canadian study suggesting that Pradaxa use with certain statins can heighten the risk for bleeding for patients suffering from atrial fibrillation. READ MORE


Posted by

had to have several cardio ablation procedures about march of 2016.was prescribed elaquis.only 3 or 4 weeks later had an in-tra cranial hemmorage requiring life saving brain surgery.had to suffer through head pain from the surgery and had nerve blocks in head,not helping, then had to have nerve under flouresance in nerve in neck to finally alleviate the pain.

Posted by

My 79-year-old grandmother suffered cardiac arrest and then uncontrollable bleeding, and died.

Posted by

Had severe bleeding from the rectum and was hospitalized for a week. Then about 2 weeks later had a stroke and was in the hospital again. The left side of body was affected: eye, arm and leg. Now in rehab.


Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free